Literature DB >> 15322490

Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma.

Vijay Varma1, Cynthia Cohen.   

Abstract

Hepatocellular carcinoma (HCC) has distinct morphologic features and can be identified in the majority of cases by routine hematoxylin and eosin (H&E)-stained formalin-fixed paraffin-embedded sections. However, distinguishing a well-differentiated HCC from normal or regenerative tissue may be very difficult in some cases, particularly in small needle aspiration or core biopsies. Furthermore, some of the unusual morphologic variants, including clear-cell, pleomorphic, and sarcomatoid variants, may be mistaken for metastases. Similarly, metastases from various primary tumors to the liver may be mistaken for primary hepatic tumors. In this overview, we summarize the immunohistochemical and molecular markers that have been developed to address these diagnostic challenges. Among the numerous diagnostic markers studied, pCEA, HepPar 1, CD34, CK 7, CK 19, CK 20, and albumin in situ (ISH) have been found to be valuable in distinguishing HCC from metastatic neoplasms of extrahepatic sites.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322490     DOI: 10.1097/01.pap.0000131822.31576.9d

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  9 in total

Review 1.  [Diagnosis and differential diagnosis of hepatocellular carcinoma].

Authors:  U Drebber; H P Dienes
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

2.  Prognostic impact of sarcomatous change of hepatocellular carcinoma in patients undergoing liver resection and liver transplantation.

Authors:  Shin Hwang; Sung-Gyu Lee; Young-Joo Lee; Chul-Soo Ahn; Ki-Hun Kim; Kwang-Min Park; Ki-Myung Moon; Deok-Bog Moon; Tae-Yong Ha; Eun-Sil Yu; Ga-Won Choi
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

3.  IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma.

Authors:  Colin D White; Hema Khurana; Dmitri V Gnatenko; Zhigang Li; Robert D Odze; David B Sacks; Valentina A Schmidt
Journal:  BMC Gastroenterol       Date:  2010-10-26       Impact factor: 3.067

4.  Intratumoral sampling variability in hepatocellular carcinoma: a case report.

Authors:  Giancarlo Senes; Daniela Fanni; Alessandro Cois; Alessandro Uccheddu; Gavino Faa
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

5.  Immunohistochemical features of the gastrointestinal tract tumors.

Authors:  Hannah H Wong; Peiguo Chu
Journal:  J Gastrointest Oncol       Date:  2012-09

6.  A long-term investigation of the anti-hepatocarcinogenic potential of an indigenous medicine comprised of Nigella sativa, Hemidesmus indicus and Smilax glabra.

Authors:  S S Iddamaldeniya; M I Thabrew; S M D N Wickramasinghe; N Ratnatunge; M G Thammitiyagodage
Journal:  J Carcinog       Date:  2006-05-09

7.  An Overview of Biomarkers and Molecular Signatures in HCC.

Authors:  Seon-Hee Yim; Yeun-Jun Chung
Journal:  Cancers (Basel)       Date:  2010-05-07       Impact factor: 6.639

8.  MiR-3613-3p affects cell proliferation and cell cycle in hepatocellular carcinoma.

Authors:  Donghui Zhang; Enqin Liu; Jian Kang; Xin Yang; Hong Liu
Journal:  Oncotarget       Date:  2017-10-10

9.  Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma.

Authors:  Zhiyu Li; Xiaolong Wu; Xinyu Bi; Yefan Zhang; Zhen Huang; Haizhen Lu; Hong Zhao; Jianjun Zhao; Jianguo Zhou; Muxing Li; Jianming Ying; Jianqiang Cai
Journal:  Chin J Cancer Res       Date:  2018-06       Impact factor: 5.087

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.